Cortex – Life Sciences Insights

04 Apr, 2023

You say “ed”, they say “ad”: The fine line between lawful educational campaigns and unlawful advertising of therapeutic goods in Australia

By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart

Companies operating in the life sciences industry play a vital role in raising awareness of diseases and other medical conditions,...

14 Mar, 2023

By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart

Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...

02 Mar, 2021

By Moritz von Hesberg

The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today. Telehealth’s...

23 Oct, 2020

By Dr Kokularajah Paheenthararajah

This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...

10 Jan, 2020

By Dr Kokularajah Paheenthararajah

The new German Digital Healthcare Act (Digitale‑Versorgung‑Gesetz/DVG), among many other groundbreaking changes, enables any physician or...

15 Jul, 2019

By Mark Franklin

DLA Piper, in conjunction with The Lawyer, is compiling a report on Digital Therapeutics, where we are now, what the future holds, the...